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Abstract

AN INVESTIGATION OF CENTRAL NERVOUS SYSTEM CONDUCTION PROPERTIES IN
DIABETES MELLITUS USING BRAINSTEM AUDITORY AND SOMATOSENSORY EVOKED
POTENTIALS
Randy L, Anderson
Department of Psychology
Major Director:

Virginia Commonwealth University, 1981

Dr. Joseph H. Porter

In this study brainstem auditory evoked potentials (BAEPs), median
nerve conduction velocities (CV) and early somatosensory evoked potentials ( SEPs), were employed as indices of neural conduction properties
in a group of young insulin dependent diabetics (five males and five
females) and a group of nondiabetic controls (five males and five females).

The median nerve CV was determined from 64 summated nerve res-

ponses recorded at the elbow,

The nerve was stimulated at the wrist

using 0,2 msec square wave electrical pulses,

The SEP was recorded from

scalp electrodes using the same median nerve stimulation technique as
for the CV measure,

The BAEPs were produced by recording responses to

7 0 dB SL clicks delivered to the right ear at a rate of 1 0 per second,
Measures of central transmission time were determined from each of the
EP modalities,
the BAEP CTT.

The time interval between BAEP waves I and V determined
SEP waves P9 to Pl4 determined the earliest SEP CTT

measure.
Comparisons between the two diagnostic groups yielded the following
results:

The diabetic group evidenced a significant (p = 0, 02) slowing

vii

of

the median nerve, 53 meters per second for the diabetic group versus

59 meters per second for the nondiabetic group,

With height covaried out,

only the SEP Pl4 latency showed a significant diagnostic group difference.
More interesting were the findings for the principal SEP CTT measure.
The diabetic group had significantly (p � 0.01) longer CTTs from P9 to
Pl4, 5.0 msec as opposed to 4,2 msec for the nondiabetic group.
diabetic group also had significantly (p

=

The

0.03) longer CTTs for the

BAEP, 4.2 msec versus 4.0 msec for the nondiabetic group.

Although the

magnitude of the diagnostic group differences are small, the median
nerve CV, SEP CTT, and BAEP CTT measures indicate that diabetic neuro
pathy is pervasive, occurring centrally, as well as peripherally, as
early as young adulthood in juvenile onset, insulin dependent diabetics,

Introduction

A number of studies have documented abnormal peripheral conduction
velocity in persons with diabetes mellitus (Horowitz & Ginsberg-Fellner,
1979; Noel, 1973; Oester, Zalis, & Radriquez, 1972; Gregerson, 1967).
Diabetic neuropathy is known to affect both sensory and motor nerves,
producing abnormalities ranging from muscle paralysis to asymptomatic
neurophysiological abnormalities such as reduced conduction velocity
(Porte, Graf, Halter, Pfeifer, & Halar, 1981; Ward, Fisher, Barnes, Jessop,
& Baker, 1971).

In contrast, there is little information available re

garding the effects of diabetes on the central nervous system (CNS).
The available information comes predominantly from postmortem identifi
cation of intracranial anatomical alterations in diabetes (DeJong, 1977).
In many of these cases, death resulted from pathology unrelated to dia
betes.

In the cases studied where death was related to diabetes, there

were multiple, possibly confounding complications involving other organ
systems.

This information gap is partly due to the relative difficulty

of measuring CNS function.
This project is an attempt to determine if metabolic abnormalities
inherent in diabetes might affect CNS function as well as peripheral
nervous system function.

The success of scalp recorded evoked potentials

in other applications suggests that they should provide accurate informa
tion about changes in function of the central nervous system as a result
of diabetic neuropathy.
1
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Brainstem evoked potentials (EPs) are electrical manifestations of
the brainstem, in the nanovolt range, occurring in response to discrete
stimulation of one of the sensory modalities.

The EP electrical energy

is volume conducted from the brainstem nuclei of origin, up through the
brain mass to the scalp where it may be detected using scalp electrodes.
Since the EPs occur on the background of ongoing EEG activity that is in
the microvolt range, it is necessary to summate EP responses from many
stimulus presentations in order to visualize the response.

With serial

summation, theoretically random background EEG activity (noise) tends to
subtract out, while the stimulus response (signal) that is temporally
locked to the stimulus presentation, adds up.

In short, the summation

process makes the EP response more prominent by improving the signal to
noise ratio.
In this study, brainstem auditory evoked potentials (BAEPs) and
early somatosensory evoked potentials (SEPs) were recorded as indices of
CNS brainstem function in previously diagnosed young adult insulin depen
dent diabetics.
muli.

The BAEPs were recorded in response to brief click sti

The SEPs were recorded in response to median nerve stimulation at

the wrist.
Two previous studies have been reported in which the SEP was used
as a measure of diabetic neuropathy (Noel, 1973; Oester � �., 1972).
However, it was used only as an index of peripheral conduction from the
site of stimulation up to wave Nl8 of the SEP (see Fig. 1, middle trace).
In this research, an attempt has been made to use the SEP as a measure
of both central and peripheral neuropathy.
The BAEP has proven to be an excellent comparative measure of CNS
neuropathy since its peripheral component, wave I, is easily delineated
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from the central components (Starr, 1978; Starr & Achor, 1979; Salamy &
McKean, 1976; Salamy, McKean, & Buda, 1975).

The integrity of the audi

tory receptor organ is verified in each participant using pure tone
audiometry.

Thus, differences in BAEP components are attributable to

the neural pathways.

Apparently, no other studies have been reported

using the BAEP as a measure of diabetic neuropathy.

Literature Review

Brainstem Auditory Evoked Potentials
Use of the brainstem auditory evoked potential (BAEP) for highly
specific localized neurologic evaluation is dependent upon determination
of the neuroanatomical correlates of each waveform.

There are four

methods used to identify neural generators of EP waveforms:

depth re

cording, lesion-making experiments, deductions from clinical cases, and
potential field analysis.

The first two methods are most always limited

to nonhuman subjects, whereas the latter two yield less specific findings.
Thus, it is necessary to use results from the first two methods to veri
fy results of the second two, and vice versa.

This process has led to a

general consensus as to the neural origins of waves I through V of the
BAEP.
Wave I arises from the potential volley along the acoustic nerve.
Wave II arises from the cochlear nuclei (first central synapse in the
pathway).
plexes,

Wave III arises in the region of the superior olivary com
Wave IV arises from tracts and nuclei of the lateral lemniscus.

Wave V arises at the level of the inferior colliculi (Chiappa, Gladstone,
& Young, 1979; Fabiani, Sohmer, Tait, Gafni, & Kinarti, 1979; Starr &
Achor, 1979; Salamy & McKean, 1976; Buchwald & Huang, 1975).
There is some speculation about the finality of these BAEP origins
or at least the implied one-to-one correspondence between given peaks
and neuroanatomical structures.

Discrete lesions can affect the amplitudes
5
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of several BAEP components with no effect on latency (Starr & Achor,
1979).

Also, isocontour maps show a distribution of potential fields

throughout the brainstem during the occurrence of wave II (Starr & Achor,
1979).

Thus it appears that several neural generators contribute simul-

taneously to the generation of individual BAEP components, whereas some
auditory structures do not contribute at all to the generation of the
BAEP (Starr & Achor, 1979).
Despite the complexity of neural origin, the BAEP is very stable
within and between individuals.

Further, the prominence of the BAEP

components makes them fairly easy to score (see Fig. 1, lower trace).
Typically, the latency of each peak is taken as the point of highest
amplitude over the peak.

Discrepancies sometimes arise due to morpholo-

gical variation in the IV-V complex.

The qualitative patterns in appear-

ance of the IV-V complex have been described by Chiappa � �- (1979).
These patterns are essentially permutations of the combined factors of
the relative height and presence or absence of the two waves:
Pattern
A

B
C
D
E
F

Morphology
A single peak in the range of V;
2 peaks; wave IV lower than V;
2 peaks; IV higher than V;
IV as a shoulder on V;
V as a shoulder on IV;
IV and V equal.

In this study, wave IV was scored as missing if the BAEP showed the A
pattern.

The BAEP shown in Fig. 1 is representative of Pattern A.

Wave

IV was scored in Pattern D cases only if the slope of an imaginary tangent line to the curve appeared to reach zero over several consecutive
digital points.
Table 1 shows representative BAEP latency and amplitude data taken
from previous publications.

One of these studies was designed to examine

.....

Table 1
Representative Brainstem Auditory Evoked Potential Data
Publication
Salamy & McKean, 1976

Harkins, McEvoy, &
Scott, 1978
Michalewski, et�.,
1980 (males only)
Michalewski, et�.,
1980 (females only)

Starr, 1977

Starr & Achor, 1975

I

II

III

Latencies (msec�

IV

CTT

V

1.57 ± 0.14

2.73 ± 0.19

3.64 ± 0.24

4.82 ± 0.23

5.55 ± 0.26

3.99 .± 0.21

1.73 .± 0.11

2.84 .± 0.13

3.77+0.11

no report

5.70 ± 0.19

3.97*

1.90+0.26

3.02 ± 0.22

3.98 ± 0.28

5.32 .± 0.24

S.96_±0.16

4.06*

1.78 .± 0.12

2.96 ± 0,12

3.82 ± 0.16

5.31 .± 0.27

5.79 ± 0.08

0.28 .± 0,08

Amelitudes {uV�
0.16 ± 0.09
0.26 ± 0.07

0.11 .± 0.10

0.30 ± 0.06

1.5

2.7

3.8

4.7

s.s

a.so±

0.06

0.24 ± 0.04

0.17 ± 0.05

0.29 _± 0.03

Michalewski, et�., **
1980 (males only)

0.31 ± 0.26

0.41 .± 0.22

0.43 .± 0.16

0.80 .± 0.31

1.10 ± 0.34

Michalewski, et�., **
1980 (females only)

0.32+0.14

o.so .±

0.35 .± 0.15

1.17 _± 0.45

1.50 ± 0.42

Scott & Harkins, 1978

0.18

no report

* CTT calculated by difference from reported data.
** Calculated as the difference between wave peak and preceeding negativity.

4.01*

3.8 .± 0.2
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sex differences in the BAEP (Michalewski, Thompson, Patterson, Bowman, &
Litzelman, 1980).

While the females in the Michalewski study tended to

have shorter latencies for all BAEP components, only the wave v latency
sex difference was statistically significant (p< 0.05).

At least one

other study had previously reported a sex difference in wave v latency
(Stockard, Stockard, & Sharbrough, 1978),
The Michalewski study (1980) also reported significantly larger am
plitudes for waves IV, V, VI, and VII among their female participants.
However these findings are presented here only for relative comparison
between the two sex groups since the Michalewski study calculated ampli
tudes as the difference between each wave peak and its preceeding negati
vity.

For this study and the other two in Table 1, the amplitude of each

component was measured from each positive peak to the subsequent
negativity.
Several studies have used components of the BAEP to obtain a measure
of transmission time through a segment of the CNS (Fabiani� al., 1979;
Starr, 1978; Starr & Achor, 1979; Salamy & McKean, 1976; Salamy��-,
1975),

Such a measure is typically referred to as central transmission

time (CTT).

The most widely used BAEP CTT measure is the time interval

between the peak of wave I and the peak of wave V.

This measure provides

a neurological evaluation of the brainstem auditory pathway that is
relatively independent of click intensity and receptor factors (Starr &
Achor, 1979),
Peripheral Conduction Velocities
Abnormalities of peripheral conduction over the primary afferent
neurons of the specific somatosensory system have a direct influence on
SEP latencies and amplitudes.

Therefore, it is necessary to assess the

9
integrity of the stimulated peripheral nerve in order to use the SEP to
evaluate putative abnormalities of the central somatosensory system
(Starr, 1978),

This assessment is typically done by recording the peri

pheral nerve volley over a given segment of the nerve with bipolar elec
trodes and calculating the conduction velocity in meters per second,
The nerve volley is evoked using the same stimulus as for the SEP re
cording,

The recorded waveform is a triphasic potential that is ini

tially positive, then strongly negative, and ending with a slow positive
component (see Fig, 1, upper trace),

The negative phase is produced by

action potentials passing beneath the recording electrodes,

The posi

tive phases can be obscured if the surface recording location is far
from the nerve fiber (Cracco, Cracco, & Anziska, 1979).

The onset laten

cy of the negative component is typically used in calculation of median
nerve conduction velocity (CV) (Desmedt & Cheron,

1980b;

Noel, 1973).

This method measures the CV of the fastest conducting afferent (large
diameter, myelinated) fibers (Greene, Brown, Braunstein, Schwartz, Asbury,
& Winegrad, 1981).
Somatosensory Evoked Potentials
SEPs are typically elicited with electrical pulses of 0. 1 to 0.5
msec duration delivered to the skin over the median nerve just proximal
to the wrist.

The electrode arrangement is bipolar with the cathode 2

to 3 cm proximal to the anode (Desmedt & Cheron, 1980b; Cracco et al.,
1979; Starr, 1978).
volts.

Stimulus rate is usually 3 to 5 pulses/sec at 50

Stimulus rate and duration are important in determining the type

of nerve fiber being stimulated.

Faster or longer pulses tend to trigger

the slower conducting A-delta and C fibers associated with pain sensation
(Schmidt,

1978)

and reduce SEP resolution.

Stimulus intensity is less

10

critical since currents lightly above threshold e1 icit maximal response
amplitudes (Starr, 1978).

SEPs are most frequently recorded from the

parietal scalp (over somatosensory cortex) with a reference electrode on
the earlobe, neck, or forehead.

A noncephalic reference electrode is

sometimes preferred because of its greater "neutrality" with respect to
the recording electrode (Desmedt & Cheron, 1980b).

However, the

noncephalic reference is subject to greater myogenic contamination.
SEPs offer the opportunity to evaluate the function of the entire
somatosensory system (Cracco � �., 1979).

However, the utility of

the SEP is dependent on precise relationships between neural generators
and SEP waveforms (Desmedt & Cheron, 1980b; Starr, 1978),

Unfortunately,

these relationships are currently much less precise than those of the
BAEP.

Not only are the neural generators somewhat speculative, but also

identification of SEP waves is different in existing publications (e.g.,
Starr, 1978 reports a Pl2 but not Pll or Pl3).
Ignoring the peak latency variations due to variations of armlength,
the early SEP to median nerve stimulation has three major positive waves
and one major negative wave within 20 msec of stimulus onset.

The first

positivity is around 9 msec (P9), the second around 11 msec (Pll).

The

third positivity typically has two lobes, one around 13 msec (Pl3) and
the other around 14 msec (Pl4).

A large negativity occurs around 19

msec (Nl8), usually with small positive waves "riding" on it,

Another

large positive wave follows Nl8 at around 22 msec (P22) (Desmedt &
Cheron, 1980b; Cracco � �., 1979) (see Fig. 1, middle trace).

P22 is

not seen in several of the taller participants in this study because its
duration is greater than the post stimulus measurement time of 25 . 5 msec,

11

Pl3 has an extremely variable morphology between individuals.
may predominate over Pl4 or be altogether missing (see Fig. 2).

It

Pl3

and Pl4 can be extremely difficult to differentiate because of the vari
able morphology of Pl3 and the latency "shifts" introduced by variations
in armlength across individuals.

This interpretation problem is further

complicated in the presence of neuropathy.

The general influence of

neuropathy is to increase peak latencies and decrease amplitudes, as a
result of demyelination, fiber loss, and/or decreased metabolic inte
grity (Cracco � �., 1979; Starr, 1978),

Finally, stimulation of the

median nerve excites some motor axons that may contaminate the SEP.
Recently, the identification of the SEP waves has been clarified by
considering "

. the conduction distances and anatomical features of

each of the three neurones making up the central somatosensory pathway
in adult man, and (attempting) to relate interpeak delays of SEP far
fields to actual conduction times along these neurones," (Desmedt &
Cheron, 1980b, p. 394).
The Desmedt & Cheron (1980b) procedure uses electrical stimulation
of the index and middle fingers in order to stimulate only sensory fibers.
The median nerve volley is then recorded at the wrist, the axilla, Erb's
point, and at the entrance to the spinal ganglion (C6-C7), as well as
from the scalp.

Further, the scalp SEP is recorded with a noncephalic

reference (on the unstimulated forearm) to substantially reduce pick up
of the early far fields at the reference electrode.

Their results show

clearly that P9 occurs before the arrival of the nerve volley at Erb's
point but after its arrival at the axilla.

Thus, the P9 wave of the

scalp recorded SEP establishes that Pll arises from passage of the affe
rent volley through the ascending dorsal column.

The Pll onset
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corresponds precisely with the arrival of the peripheral nerve volley at
the spinal cord (Desmedt & Cheron, 1980b).
After careful consideration of the geometry of the ascending central
somatosensory pathway, Desmedt & Cheron (1980b) were able to establish
that the Pl3 and Pl4 generators are below the thalamus but above the
foramen magnum.

It appears that the lemniscal volley has just begun to

activate the ventro-basal thalamic neurones at Pl4 onset (Desmedt &
Cheron, 1980b).

This conclusion is in agreement with a report by

Greenberg, Mayer, Becker, & Miller (1977) that this wave has no thalamic
or cortical component because they have recorded it in five patients with
electrical and clinical brain death.

Desmedt & Cheron (1980b) conclude

that Nl8 is the response of cortical projection of the afferent volley.
Thus, the descending (positive up) limb of Nl8 can be used as a marker
for estimating the cortical SEP latency.

Desmedt & Cheron (1980b)

believe that Nl8 is related to postsynaptic potentials elicited in apical
dendrites of pyramidal neurones.
Diabetic Neuropathy
The term, diabetic polyneuropathy, describes a multiplicity of
neuronal degenerative anomalies associated with diabetes mellitus.

Peri

pherally, the major manifestation of diabetic neuropathy is reduced con
duction velocity in sensory and motor nerves.

The presence of neuropathy

in long standing insulin dependent diabetics is not universal (Pirart,
1978).

However histological and electrophysiological evidence suggests

that the reduced CV is the result of demyelination and subsequent loss
of nerve fibers (Noel, 1973) beginning well before clinical manifesta
tions (Greene et al., 1981).

The degree of glycemic control and duration

of diabetes are major determinants of the progression of the degenerative
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process (Porte� al., 1981; Greene et�., 1981; Horowitz & Ginsberg
Fellner, 1979; Pirart, 1978; Skyler, Lasky, Skyler, Robertson, & Mintz,
1978; Ward et al., 1971; Gregerson, 1967).

Indeed, careful management

of blood glucose has been shown to reverse the degenerative process to
some extent (Ward��., 1971) with the potential reversal probably
limited by the degree of large fiber loss (Greene��., 1981).
Diabetic neuropathy sometimes involves weakened neuromuscular transmission mechanisms (Miglietta, 1973), altered pupillary reflexes
(Hreidarsson, 1981) as well as reduced skin sensitivity to temperature,
pin prick, proprioception, and vibration (Greene� al., 1981).

While

it is well established that these and other processes affected by diabetes are the result of primary neuronal changes, it is not certain whether
the central mediation of these processes is affected.
transmission mechanisms are affected

Neuromuscular

in some diabetics resulting in a

decline in muscle action potentials with high stimulation frequency (20SO per second) (Miglietta, 1973).

The decline in neuromuscular transmis-

sion is observed in some diabetics despite their having normal CVs
(Miglietta, 1973).

Some motor fibers are apparently immune to this de-

crement, such as those serving the fingers (Miglietta, 1973).

Abnormali-

ties of pupil unrest are known to occur during hyperglycemia (Hreidarsson,
1981).

Since the control of pupillary unrest is of central origin (see

Hreidarsson, 1981), it is possible that the abnormalities associated with
hyperglycemia are directly related to the effects of hyperglycemia on the
central autonomic nervous system (Hreidarsson, 1981).
Electroencephalographic studies show a higher incidence in diabetics
of abnormally slow and abnormally fast waves (DeJong, 1977).

These
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abnormalities appear to be associated with recurrent hypoglycemia
(DeJong, 1977).
Gupta and Dorfman (1981) have reported longer spinal conduction
times in a heterogeneous group of diabetics, but no difference in supra
spinal (cervical cord to cortex) conduction.

They used an indirect

method of calculating spinal transit time and supraspinal transit time
(Dorfman, 1977) from the SEP.

They suggest that the supraspinal segment

of the somatosensory pathway is more resistant to diabetic neuropathy.
In cases of diabetic neuropathy, sensory nerve potentials show re
duced amplitude, a less well defined shape, and increased latency of
the initial peak (Noel, 1973).

Lesions of the central somatosensory

pathway are expected to affect the appearance of the SEP in the same
three ways (Oester � �-, 1972).
The central purpose of this investigation was to determine, in the
most direct way possible, if a group of young adult insulin dependent
diabetics evidence altered neuronal function within the CNS, as measured
with scalp recorded EPs.

Methods

Subjects
Persons between the ages of 20 and 30 were recruited for participation in this study using fliers posted around the university campus,
When potential participants reported to the EP lab, the entire testing
procedure was explained, followed by an opportunity to ask questions,
Written consent was then obtained from each participant,
$5,00 per hour of participation.

All were paid

Responses to the screening question-

naire were used to exclude individuals who had a potentially confounding
medical history,
diabetics,

The questionnaire identified two such cases, both

The first had diagnosed peripheral neuropathy that had pro-

duced temporary paralysis of the legs, as well as a history of neurologic
seizures,

The second individual was approximately 80 pounds over

reccxrunended body weight for his height and build,
After completion of the screening questionnaire, a urine sample was
collected from each participant,

Each sample was tested immediately for

R KETO-DIASTIX),

presence of glucose and ketones (AMES

No member of the

nondiabetic group had previous evidence of diabetes nor did any show
positive urinalysis results,

All diabetics showed presence of urine glu-

cose on either the first urine sample or a second sample taken halfway
through EP testing (see Table 2).

Therefore, these tests verified the

self-report diagnostic classification of the diabetics.
participants showed urine ketones in either urine sample,
16

None of the 20

......
......

Table 2
Urine Glucose Test Results
First
Urinalysis
mg/dL
DIABETICS:
Female
n

Male
n
NONDIABETICS:
Female
n
Male

Second
Urinalysis
mg/dL

0.07

.±

0.06

1.00 +

0.75

.±

0.96

0.71 + 0.87

3

4

4

4

0

N/A

0

N/A

s
s

o. 82

18
An audiogram was completed on each participant to establish hearing
efficacy.

The audiograms were collected in a quiet room using a Beltone

portable audiometer.

None of the 20 participants showed a hearing defi

cit greater than 30 dB at any of eleven frequency bands between 125 Hz
and 8000 Hz (see Fig. 3).

Furthermore, the two groups did not differ

significantly over any of the eleven frequency bands, nor did hearing
threshold to the BAEP click stimulus show a significant group difference.
One nondiabetic individual was excluded from participation based on the
audiogram.

This individual had hearing thresholds of 45 dB over three

frequency bands in both ears.
All ten diabetic participants met the following inclusion criteria:
1) insulin dependent from first diagnosis; 2) no previously diagnosed
neuropathy; 3) body weight within ten pounds of ideal for height and
build (Metropolitan Life Insurance statistics); 4) no history of any
other metabolic or neurological disease.
age fo 23.9

±

3.4 years (range of 20 to 30 years) and consisted of five

males and five females.
5.8 years

The mean duration since diagnosis was 7.8 +

(range of 2.5 to

17

years).

also had five males and five females.

±

The diabetic group had a mean

The nondiabetic control group
Mean age for this group was 26.

1

3.3 years (range of 20 to 30 years).

Procedure
Stimuli for the BAEPs were 70 dB SL condensation phase click sounds
generated by passing 0.1 msec square wave electrical pulses through TDH49 headphones.
second.

Stimulation was to the right ear at a rate of ten per

BAEPs were recorded from vertex (Cz) referenced to the right

mas t 01."d process, w1."th a o�round electrode clipped to the right earlobe

20
(Scott & Harkins, 1978; Harkins , McEvoy, & Scott, 1978·
, p·icton, H"ll
i yard ,
Krausz, & Galambos, 1974).
Stimuli for the SEPs and the median nerve CV measures were 0.5 msec
square wave electrical pulses delivered three per second to the left
median nerve just proximal to the wrist.
to the anode.

The cathode was two cm proximal

A ground electrode was placed on the inner surface of the

forearm midway between the wrist and elbow.
volts.

Stimulation voltage was 50

The thumb twitch motor threshold established stimulus intensity

for each case (Starr, 1978).

The stimuli were generated by a Grass S88

stimulator, a stimulus isolation unit, and a constant current unit
connected in series.
SEPs were recorded from a parasagital electrode placed over the contralateral hand representation area of somatosensory cortex (one cm inferior and one cm posterior to C4 of the International 10-20 system of
cephalic electrode placement).

The cephalic electrode was referenced to

a nuchal electrode between cervical vertebrae five and six (Harkins &
Dong, 1980).
The electrophysiological responses being measured were amplified by
a Grass P511J preamplifier set at a gain of 5 x 10 4 with filters at 10
Hz and 3000 Hz.

A Nicolet 1074 signal summator was used to process the

EEG for EPs and to determine the mixed nerve CV to median nerve stimulation.

A bin width of 100 usec was employed for collecting the SEPs and

the CV measures.

Bin width was 50 usec for the BAEPs.

the EEG was continuously monitored.

During summation,

Processing was stopped when muscle

or other artifacts were apparent (Chiappa � �., 1979).

For both EP

modalities, four consecutive traces of 1024 stimulus presentations each
were overlapped to permit determination of response stability.

The
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median nerve CV measure was determined from two repeated traces of 64
stimulus presentations each,

Once collected, the EPs were plotted out

from the signal sununator using an X-Y plotter,

The important points

were designated and the corresponding digital values for latency and
amplitude of each point were taken from the signal summator memory,
The digital values were then entered into VCU's IBM 370 computer, along
with other data on each participant, for subsequent processing using the
Statistical Analysis System (SAS).·

Results

Separate three-way analyses of variance (diagnosis x sex x diagnosis
sex interaction) were performed on all dependent variables except those
of the aud iograms and urinalysis results.
performed using the ANOVA procedure of SAS.
using the CORR procedure of SAS.

The analyses of variance were
Correlations were performed

In the following account of the results,

statistically significant differences between the diabetics and nondiabetics are referred to as diagnostic group differences, whereas statistically significant differences between females and males are referred to
as sex group differences.
As a check for equivalent auditory reception in each diagnostic
group, the group means for each frequency band of the audiograms were
compared using t-tests.

There was no significant diagnostic group dif-

ference at any of the levels tested (see Fig. 3).

The anaLysis of vari-

ance for a difference in click stimulus threshold also showed no diagnostic group significance (see Table 3) (n's may vary throughout all tables
because of missing values).

Thus it appears that any group differences

in the BAEP measure did not result from an influence of diabetes on the
auditory receptor.
There was also no diagnostic group difference in sensory or motor
threshold to the electrical stimulus, evidencing the absence of any symptomatic deficits in the diabetics (see Table 3).

The females as a group

had significantly lower sensory thresholds than did the males.
motor thresholds showed no significant sex group differenc e.
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However,

Table 3

("')
N

Stimulus Response Parameters, Height and Weight Data

DIABETICS:
Female
n
Male
n

NONDIABETICS:
Female
n
Male
n

DIAGNOSIS:
F
SEX:

.E
F

.E
D IAGNOSIS & SEX
INTERACTION:
F

E

Click
Threshold
(dB)

Sensory
Threshold
(mA)

Motor
Threshold
(mA)

Height

Weight

9 + 4
5

0.5 + 0.05

4.7 + 2.11
4

63.7+2.l
5

123.6 ± 5.9
5

64.1+2.5
5

120.8 ± 9.8
5

4

11+4
5

0.7 ± 0.46
5

13

0.4 ± 0. 1 0
5

4.8_±2.11
5

0.9
0.35

0.1
o. 79

0.01
0.93

2.4
0.14

6.3
0.02

0.04
0.85

5.26
0.04

1. 3
0.27

64.9
0.000 1

55.8
0.0001

0.3
0.58

0.6
0.45

0
1.00

1.1
0.30

12

+ 9

s

+ 4
5

0.8 + 0.25
5

5.8 ± 2.20
5

5.7_±0.97
5

69.6 +
5

1 .8

71.8 ± 0.4
5

145.4 � 12.7
5

173.2 _± 14.2
5

9.5
0.007
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Summary statistics for the BAEP latencies
are presented in Table 4,

along with the results of the ANOVA comparison
s for each of the four
groups,

The component latencies are slightly slower
in the diabetics,

However, the differ ences do not show significance
.

At wave

v

the dia-

betics are about 0, 2 msec slower than the nondiabetics (
p = o . 06) •

The

differences are small relative to the standard deviations, however
the
trend is consistent,

Figure 4 illustrates the accumulation of diagnostic

group latency differences over the interwave intervals from wave I to
wave V,
The BAEP amplitudes were measured as the height of each waveform
from its right base up to its peak,

This distance measure was converted

to microvolt (uV) units using a calibration square wave pulse of known
voltage that was summated in the same way as the scalp recorded responses,
Swmnary

statistics for the BAEP amplitudes are presented in Table 5.

Amplitudes for waves I, III, and V were tested for group differences,
Females tended to have slightly larger wave V amplitudes (p

=

0.05),

however, there was no significant diagnostic group difference (see
Michalewski et

!!l·,

1980)

CTT for the BAEP was calculated by subtracting wave I latency from
wave V latency (Starr, 1978; Starr & Achor, 1979; Salamy & McKean, 1976;
Salamy� al., 1975),
in Table 6.

Summary statistics for the measure are presented

Mean BAEP CTT for the diabetic group is about 0.2 msec long-

er than for the nondiabetics, just as for wave V latency (diabetic mean
4. 2 msec, nondiabetic mean = 4.0 msec).
shows significance (p = 0.03),

The diagnostic group difference

The slower CTT suggests that diabetes

may have begun to affect the metabolic integrity of the brainstem audi
tory pathway.

However, the absence of any difference in the overall

=

"'
N

Table 4
Brainstem Auditory Evoked Potential Latencies
(msec)
I

DIABETICS:
Female
n

III

IV

V

VI

VII

1.43+0.13

2.59+0.11

3.71+0.13

4.90+0.20

5.59+0.33

6.91+0.17 8.63+0.18

3

Male
n

1.49 .± o. 14
5

4

2.63 .± 0.10
5

3.66 .± 0.11
5

4.65+0.05

5.67 .± 0.06
5

7.31+0.35

8.95 .± 0.65
5

2.51+0.21

Male
n

1.51 .± 0.09
5
1.47 .± 0.03
5

2.52 .± 0.04
5

3.64 .± 0.30
5
3.60 .± 0.16
5

4.60+0.13 5.40
4
4.70+0.25 5.50
5

F

0.4
0.56

2.6
0.13

0.5
0.49

1.2
0.30

4.1
0.06

0.4
0.56

0.7
0.41

F

0.03
0.87

0.2
0.68

0.2
0.64

0.4
0.52

1. 3
0.28

4.1
0.06

0.7
0.42

1.2
0.29

0.1

0.04
0.84

2.6
0.14

0
1,00

0.04
0.85

0.2
0.66

NONDIABETICS:
Female
n

DIAGNOSIS:
SEX:

II

.£
.£

DIAGNOSIS & SEX
INTERACTION:
F

.E

4

4

4

o. 77

4

3

3

4

4

.± o. 11 6.48 .± 0.45 8.64+0.32
4
5
5
.± 0.22 7.17 .± 0.43 8.58 .± 0.25
2
5
5

I

r-

Table 5

N

Brainstem Auditory Evoked Potential Amplitudes
(uV)
DIABETICS:
Female
n
Male
n
NONDIABETICS:
Female
n

Male
n

DIAGNOSIS:
F
.£
SEX:
F

.£
DIAGNOSIS & SEX
INTERACTION:
F
.£

Ratio of
V to I

I

III

V

0.36+0.22

0.28+0.13

0,58+0.15

2.79+3.14

0.31+0.08
5

0.28

.±

0.13

0.50+0.12
5

1,67 _± 0.65
5

0,27 _± 0,06
4

0.18

.±

0.007

o.70+0.21

2.71+1.18

0,28

.±

0.12

0,48

.±

2.19 +1.30
4

4

0.26 _± 0.13
4

4
5

3

4

4

4

4

0.12

4

4

1.0
0.33

0.5
0.49

0.4
0.52

0.1
o. 76

0.2
0.67

0.5
0.48

4.5
0.05

1.0
0.34

0.1
o. 77

o.7
0.42

1.1
0.32

0.1
o. 72

Table 6

co
N

Central Transmission Times and Median Nerve Conduction Velocities

DIABETICS:
Female
n
Male
n
NONDIABETICS:
Female
n
Male
n
DIAGNOSIS:
F
£
SEX:
F
£
DIAGNISOS & SEX
INTERACTION:
F
£

BAEP
I to V
(msec)

SEP
P9 to Pl4
(msec)

4.16 + 0.33
4.18 _± 0.10
5

4. 78 _± 1.08
4
4.90 _± 0.22
4

4.52 _± 0.65
5
4.74 _± 0.61
5

49.8 _± 5.3
5
55.9 _± 5.7
3

3.89 _± 0.12
5
4.03 _± 0.21
5

3.80 + 0.35
5
4.31 _± 0.21
4

5.38 + 0.44
5
5.82 _± 0.99
5

59.3 + 5.8

5.5
0.03

8.1
0.01

9.6
0.007

7 .4
0,02

1.1
0.32

2.0
0.18

1.1
0.31

2.3
0.15

0.2
0.66

0.2
0.69

0.1
0.73

1. 2
0.29

4

SEP
Pl4 to Nl8
(msec)

Median
Nerve CV
(m/sec)

4

59.3 .± 4.0
5
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appearance of the BAEP suggests that no morphological changes have
occurred.
The median nerve CV measure was calculated by dividing the distance
between the stimulating electrodes and the recording electrode by the
latency of the nerve volley, recorded at the elbow (see Fig. 1) (Cracco
� �., 1 9 7 9 ).

The latency of the nerve volley was taken as the peak

of the initial positivity, which corresponds to the onset of the negative
component.

Some of the median nerve volley recordings, while sufficient

for latency determinations, are of poor quality because the recording
electrode was not always directly over the nerve fiber.

Use of a mobile

recording probe would have permitted more precise location of the nerve.
The median nerve CV results are summarized in Table 6 along with the
CTTs.

As expected, median nerve CV was significantly slower among the

diabetics, indicating the presence of peripheral neuropathy (p
(diabetic mean = 52.8, nondiabetic mean

=

59,3).

=

0.02)

The diagnostic group

means differ by about 6.5 m/sec.
Summary statistics for SEP latencies are presented in Table 7A
along with analysis of variance results.

The diabetics have slightly

longer latencies for the first three components with only the Pl4 differ
ence showing significance.

However, the Pl4 diagnostic group difference

is relatively dramatic (p = 0.003) (diabetic mean
mean = 13. 9 ).

=

14 .8, nondiabetic

Pl4 is delayed by about 0. 9 msec in the diabetic group.

This difference disappears at Nl8, suggesting a reduction in terminal
branching of the thalamocortical radiations (Desmedt & Cheron, 1980c),
(diabetic mean = 19.3 msec, nondiabetic mean

=

1 9. 4 msec).

Figure 5 il

lustrates the changing relationship of the diagnostic group latency
differences over the interNave intervals from P 9 to P22.

Table 7A

0
<'"I

P9
DIABETICS:

P22
22.72 .:!: 0.93
5
23.25 +1.03

9.71 +o.94
4

12.23 +0.42

14.52 +0.23

19.04 +0.72

9.90+0.74
4

12.40 .:!: 0.98
3

14.92 .:!: 0.67
5

19.66 .:!: 1.23
5

Female
n
Male
n

9.14 ± 0.73
5
0.33
10.18
4

11.15 +0.83

12.94 .:!: 0.83
5
14.64 .:!: 0,43
5

18.32 .:!: 0.90
5
20.46 .:!: 1.10
5

DIAGNOSIS:

±

4

4

12.82 ± 0.58

s

s

4

22,63 +0,59

4

22. 95 .:!: 1.06
2

F
.E

0.5
0.51

12.5
0.003

0.01
0.93

0,2
0.65

F

3.1
0, 10

15. 9
0.001

9.4
0.007

1. 0
0.34

1.6
0.23

6.1
0,03

2.8
0.11

0
1.00

.E
DIAGNOSIS & SEX
INTERACTION:

F

.E

*

Nl8

Female
n
Male
n

NONDIABETICS:

SEX:

Somatosensory Evoked Potential Latencies
(msec)
Pl2k
Pl4

Incorrectly designated as Pl2 rather than Pll and Pl).

.....

(')

14-
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Figure 5: Display of the accumulation of interwave transmission time differences over the entire SEP. The
diagnostic group difference reaches significance only for the P9 to Pl4 segment in this figure. (The P14 to
Nl8 segment is significantly shorter among the diabetic group, however this segment is hidden in the P9 to
Nl8 segment depicted here,)
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The difference in P9 latencies is unexpected
ly small given the

difference in median nerve CV between the two groups
(see Table 6).

If

P9 originated at the level of the axilla (Desmedt & Cheron,
1980b), the

median nerve CV difference would be expected to produce about a
0.9 msec
delay in P9 latency in the diabetics, given an arm length of 45 cm.

A

group arm length difference may have been responsible for the 0.7 msec
discrepancy (0.9(expected) - 0.2(actual)

=

0.7).

The nondiabetic males

tended to be taller and heavier than the diabetic males while the female
participants were more homogeneous in height and weight.

The differ-

ences are reflected in the diagnostic group means given in Table 3.
This height discrepancy may have influenced the SEP latencies.

Since

height is related to arm length, there is reason to expect that height
may have biased the SEP latencies in the taller nondiabetics, thereby
disguising the influence of diabetes on the SEP latencies of the shorter
diabetics.

As an attempt to account for the height influence, analyses

of co-variance were repeated on the SEP latencies with height covaried
out (see Table 7B).

Since the females were homogeneous with respect to

height, it is interesting to note the larger difference in P9 latencies
between the two groups of females.

The P9 difference (0. 7 msec) is more

congruent with the median nerve CV findings.
Summary statistics for SEP amplitudes are presented in Table 8.
SEP amplitudes were calculated as they were for the BAEP amplitudes, with
the exception of Nl8.

Nl8 amplitude represents the vertical displacement

from the lowest point of Nl8 up to the highest point of P22.

The diabe

tics have dramatically lower amplitudes for Pl4 and Nl8 (p = 0.004 and p
0.007, respectively).

These measures of the descending (Pl4) and ascen

ding (Nl8) limbs of the Nl8 wave are probably closely related.

Thus, the

Table 7B

(")
(")

Somatosensory Evoked Potential Latencies with Height Covaried Out
P9

Pl4

Nl8

P22

12,1
0,003

8, l
0,01

12,8
0,002

1. 8
0,21

F

0,8
0,47

10,9
0,001

0,1
0,88

0,2
0,81

F

0,9
0,36

0,3
0, S 7

0
0,95

0,01
0,94

1,1
0,31

s.o

1,8
0,20

0,1
0,76

HEIGHT:
F

.E

--

DIAGNOSIS:
SEX:

(msec)

.E
.E

DIAGNOSIS & SEX
INTERACTION:
F

.E

0,04

Table 8

..j
C")

Somatosensory Evoked Potential Amplitudes
Pl2

P14

Nl8

0.21 + 0.30
2

0.05 ± 0.01
3

3.41 ± 1.17
5

2.81 ± 0.77
5

Female

0.21+0.17

0.32+0.15

4.20+2.00

Male

0.36 ± 0.05
4

0.10 + 0.08
5

4.85 ± 0.41
5
4.31 + 1.23
5

DIABETIC:

Female
n

Male
n

NONDIABETIC:

n

n

DIAGNOSIS:

F

.£

SEX:

(uV)

F
.£

DIAGNOSIS & SEX
INTERACT ION:

F

.£

P9

0.22 ± 0.13
4

4

0.23+0.25
3

4

2.83 ± 0.83
5

2.03 ± 0.70
4

4

5.24 ± 0.45
2

0.6
0.44

11.4
0.004

10.7
0.007

0.9
0.38

1.7
0.21

0.3
0.62

1.0
0.35

0
1.0

1.7
0.23
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Pl4 and Nl8 amplitude measures may actually reflect the same thing:

a

relatively smaller negative displacement of the lowest point of Nl8 among
the diabetics.

No other SEP amplitudes showed any significant group

difference.
Summary statistics for two SEP CTT measures are presented in Table
6.

The P9 to Pl4 measure is the conduction time from the peak of the

first component of the early SEP up to the peak of the most prominent
early positivity.

The Pl4 to Nl8 measure is the conduction time from

the most prominent early positivity up to the most prominent early negativity, corresponding to the brainstem-to-thalamocortical transition
(Desmedt & Cheron, 1980b).

Like the BAEP CTT, both of the SEP CTT mea-

sures show a significant diagnostic group difference.

However, the

The diabetics have a longer

directions of the two SEP CTTs are opposite.

CTT from P9 to Pl4 while the Pl4 to Nl8 segment is shorter in this group.
Recall that the diabetics also had significantly reduced amplitudes on
the descending and ascending limbs of Nl8.

As with the smaller Pl4 and

Nl8 amplitudes among the diabetics, the shorter Pl4 to Nl8 segment might
also reflect a reduction in terminal branching of the thalamocortical
radiations.
A plot of each participants' BAEP CTT versus his/her SEP CTT (P9 to
Pl4) shows a strong linear trend (see Fig. 6).

This relationship implies

that the longer CTTs observed in the diabetics occur together in both
modalities and reflect a mild but pervasive metabolic influence of dia
betes throughout the CNS.

The plot reflects to a degree the same find

ings as the analyses of variance tests for the CTTs.

However, correla

tions of the BAEP CTT and the SEP CTT, by diagnostic classification,
reveal additional information about the relationship.

There is a
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significant correlation between the two CTTs among the diabetics (r
p

0 , 86 ,

=

0 , 0 1),

but not among the nondiabetics (r

=

0.31,

p

=

=

0,42),

The degree of peripheral nerve diahetic neuropathy has been shown
repeatedly to be inversely related to the degree of glycemic control
(Greene��., 19 81; Porte� al., 19 8 1; Horowitz & Ginsberg-Fellner,
1979; Pirart, 197 8; Skyler� al,, 197 8; Ward��., 1971; Gregerson,
1967).

Better blood glucose control is associated with less peripheral

neuropathy,

Looking at Fig, 6, it appears that the large BAEP CTT

SEP CTT correlation among the diabetics is a result of the greater dis
persion of the diabetics along the regression line,

This finding sug

gests that not all the diabetics show a diagnostic effect,

Furthermore,

the dispersion may be related to the degree of glycemic control, as it
is at the peripheral level,

The demonstration of a relationship between

CTTs and glycemic abnormality would verify that longer CTTs in diabetics
are a result of glycemic abnormality and validate the use of EPs to
diagnose CNS diabetic neuropathy.

Discussion

The diabetic group in this study evidenced significant slowing of
median nerve conduction velocity, indicative of peripheral nerve diabetic neuropathy.

Furthermore, the three CTT measures reported in this

study each showed a significant diagnostic group difference, suggesting
a detrimental effect of diabetes on CNS function.

However, the direction

of the diagnostic group difference was not the same for the three CTT
measures.

The BAEP CTT (wave I to wave V) and the SEP CTT (P9 to Pl4),

both of early brainstem origin, were significantly longer in the diabetic group,probably reflecting slowed central conduction.

The SEP CTT

(Pl4 to Nl8), of midbrain origin, was significantly shorter in the diabetics, possibly reflecting a reduction in thalamocortical radiations
(Desmedt & Cheron, 1980b).

More definitive statements of the meaning of

t hese findings await the resolution of measurement problems and a better
knowledge of the neural origins of the EP waveforms.
The group means for the SEP CTTs suggest a serious question concerning accurate designation of the Pl4 component in the nondiabetics.

As

an extension of the nomenclature, the anticipated CTT from P9 to Pl4 is
about 5 msec.

The anticipated CTT from Pl4 to Nl8 is about 4 msec.

These values appear essentially reversed in the nondiabetics, with P9 to
Pl4 being about 4 msec, and Pl4 to Nl8 being over 5 msec (Table 6).

One

could argue that the component designated as Pl4 in the nondiabetics is
actually Pl3 and that the diagnostic group difference in the CTTs merely
38
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Desmed t & Cheron ( 1 980b) have pointed

reflects the "misdesignation".

out how Pl3 can be incorrectly designated as Pl4 (see Fig. 2) when Pl3
is inordinately large and predominates over Pl4.

To further exacerbate

the uncertainty a small PlS is sometimes present on the descending limb
of Pl4, mimicking the Pl3-Pl4 condition in the lower SEP of Fig. 2
(Desmedt & Cheron,

1 980b;

Starr,

1978;

Greenberg et al., 1977).

It is

possible that the naming of PlS is actually an error of misinterpreting
the Pl3 and Pl4 waves in taller individuals.
The issue of correct designation is much more complex than just mere
variation in wave morphology.

Given a CV of 60 m/sec, an average of

about 0. 1 7 msec is required for each cm of conduction distance over the
median nerve.

Desmedt & Cheron ( 1 980c) have attributed differences of

as much as 2 msec in P9 onset latency to intrasubject differences in arm
length.

Thus, it is not unreasonable that the P9 wave could have a peak

latency of as low as 7 msec or as high as 1 1 msec among normal indivi-.
duals with identical median nerve CVs, because of inter-individual
differences in the length of the nerve pathway.

The polarity-latency

combination nomenclature is only a representation of mean peak latencies
from large samples where height is ignored as a factor.

It is unreliable

as a rigid guideline for designation of SEP components.
When comparing SEPs from a group that is heterogeneous with respect
to height, the largest component of height-related variation in peak
latencies arises from the longest segment of the stimulated pathway,
that is, from the stimulation site up to the axilla (vicinity of P9 ori
gin).

However, it is important to realize that this component is not

the only component of height related variation in peak latencies.

It is

reasonable to assume that height is related to body size and that it
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tends to be distributed proportionally over th
�·
e enLire
vertica
· 1 axis.

Therefore, it is expected that taller individuals would tend
to have a
greater chest girth also.

"'ssuming
that one-ha 1 f of chest girth closely
·

corresponds to the nerve pathway length from the axilla to the point of
spinal entry (onset of Pll), it is expected that taller individuals
should have a greater conduction·time between the peaks ot pg and Pll.
However, this component of height related variation in peak latencies is
smaller than that of the first segment (stimulus onset up to peak of P9)
because the nerve segment is shorter.

An analogous argument applies for

the remaining peak-to-peak segments of the SEP.
be generally stated as follows:

The two major points can

1) not only is height directly related

to SEP latencies, but also it is related to the interpeak latencies.
Thus, the height effect cannot be subtracted as an overall constant from
each peak latency.

However, 2) the height related variation in interpeak

latencies should be proportional to the length of the nerve segment between the two peaks involved.

Thus, the height factor should be less

significant for shorter caudal segments of the nerve pathway than it is
for longer rostral segments.

These relationships are problematic when

the SEP is used to determine impaired CNS function because the putative
disease effect will be similar to the height effect.

Therefore, the

height effect must be accurately assessed in order to draw sound conclu
sions concerning group differE:nces in peak latencies and interpeak distances, as they reflect neural processes.

Clearly, the covariance ap-

proach employed in this study was effective in dealing with height
related variation in the SEPs.

However, the covariance approach was

limited in that the height related variation may have hampered correct
designation of the component peaks.

Where peaks P9, Pll, and Pl3 are
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involved, the height related variation is best controlled by recording
the nerve volley at the axilla (origin of P9) and over cervical verte
brae 6 and 7 (onset of Pll) (Desmedt & Cheron, 1980b).

These recordings

allow accurate designation of the scalp recorded P9 and Pll by essenti
ally having recorded the potential from two points that give the same
latencies as the scalp recorded SEP.

Such a tight designation of P9 and

Pll reduces the difficulty in accurately designting Pl3 and Pl4 thereby
making the differences induced by any disease factor more detectable.
In this study, the scalp recorded SEPs were extensively evaluated to
insure accurate designation of the components.

Since axilla and neck EPs

were not recorded, the scalp SEP peaks were designated based on their
overall appearance and to a degree, on the anticipated nominative peak
latencies.

Knowledge of the diagnostic group classification was not con-

sidered during the initial scoring.

The data were then entered into the

computer for calculation of summary statistics.
were then checked for validity.

Outlying observations

Finally, the SEPs were rescored a second

time from scratch with any scoring differences thoroughly reconsidered
by Dr. Harkins and myself.

In light of the new information concerning

Pll and P13 (rather than Pl2), the SEPs will be rescored a third time
prior to any further publication.
More research needs to be done to clarify the components of the SEP,
their origins, and factors influencing their appearance.

Unlike the BAEP,

it is not possible to clearly interpret the SEP findings presented here
until such information is available.
consistencies.

Nonetheless, there are some notable

The BAEP CTT, PCV, and SEP CTT (P9 to Pl4) for the dia-

betic group are all in the expected direction.

Thus, it appears that,

out the
among d.iab et·ics, conduction times tend to be longer through
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nervous system.

These findings are analogous to age differences obser

ved by Desmedt & Cheron (1980 a & c) in a group of octogenarians.

Gupta

and Dorfman (1981) have observed a similar trend in a heterogeneous
group of diabetics, except they found no differences at the supraspinal
level.

However, their technique involved estimation of several para

meters that would be affected by diabetic neuropathy.

It is not clear

whether assumptions involved in these estimations remain valid in cases
of diabetic neuropathy (see Dorfman, 1977 for technique of estimating
conduction time based on the F-wave motorneuron backfiring phenomenon).
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